Skip to contentSpiegel Robert J. — GERON CORP insider: 162 transactions · InsiderLensSpiegel Robert J.
- Director at RenovoRx, Inc. · on record since Apr 27, 2023
- Director at CAPRIUS INC · on record since May 25, 2010
- Director at GERON CORP · on record since May 21, 2010
- Director at Hana Biosciences Inc · on record since Aug 3, 2010
- Chief Medical Officer at PTC THERAPEUTICS, INC. · on record since Feb 28, 2014
- Director at Sucampo Pharmaceuticals, Inc. · on record since Jan 26, 2015
- Director at Edge Therapeutics, Inc. · on record since Sep 30, 2015
- Director at XCYTE THERAPIES INC · on record since Sep 10, 2018
- Director at Ayala Pharmaceuticals, Inc. · on record since May 7, 2020
- Director at Athenex, Inc. · on record since Aug 12, 2020
- Director at Advaxis, Inc. · on record since Jan 23, 2023
Insider trading activity of Spiegel Robert J.
- Transactions on record
- 162
- since May 25, 2010
- Open-market buys
- 1
- Open-market sells
- 9
- $1.3M
- Companies traded
- 11
- last filing Jul 1, 2026
Figures computed from official regulatory filings — methodology.
Companies where Spiegel Robert J. has traded
- GERON CORP94 tx · $1.8M · Jul 1, 2026
- RenovoRx, Inc.6 tx · Oct 2, 2025
- XCYTE THERAPIES INC9 tx · Jul 3, 2023
- Athenex, Inc.11 tx · $15.1K · Apr 24, 2023
- Advaxis, Inc.4 tx · Jan 23, 2023
- Ayala Pharmaceuticals, Inc.6 tx · Jan 23, 2023
- Edge Therapeutics, Inc.5 tx · $152.3K · Mar 18, 2019
- Sucampo Pharmaceuticals, Inc.9 tx · $323.5K · Feb 13, 2018
- PTC THERAPEUTICS, INC.6 tx · $5.7M · Jan 6, 2016
- Hana Biosciences Inc
Track record of Spiegel Robert J.
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Spiegel Robert J.
Co-insiders of Spiegel Robert J.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
8 tx · Jul 18, 2013
Schindel Yair ChaimAdvaxis, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 1, 2026 | Award | 6,103 | 1.28 USD | — | SEC |
| May 26, 2026 | AwardD | 220,000 | 0.00 USD | $0 | SEC |
| Apr 1, 2026 | Award | 5,243 | 1.49 USD | $7.8K | SEC |
| Jan 5, 2026 | Award | 5,918 | 1.32 USD | $7.8K | SEC |
| Oct 2, 2025 | AwardD | 47,640 | 0.00 USD | $0 | SEC |
| Oct 1, 2025 | Award | 5,702 | 1.37 USD | $7.8K | SEC |
| Jul 1, 2025 | Award | 5,540 | 1.41 USD | $7.8K | SEC |
| May 22, 2025 | AwardD | 180,000 | 0.00 USD | $0 | SEC |
| Apr 2, 2025 | Award | 2,206 | 3.54 USD | $7.8K | SEC |
| Apr 2, 2025 | Award | 2,462 | 3.30 USD | $8.1K | SEC |
| Apr 2, 2025 | Award | 4,913 | 1.59 USD | $7.8K | SEC |
| Apr 2, 2025 | Award | 1,767 | 4.54 USD | $8K | SEC |
| Apr 2, 2025 | Award | 1,916 | 4.24 USD | $8.1K | SEC |
| Oct 2, 2024 | AwardD | 25,099 | 0.00 USD | $0 | SEC |
| May 10, 2024 | AwardD | 180,000 | 0.00 USD | $0 | SEC |
| Jan 30, 2024 | BuyD | 40,983 | — | — | SEC |
| Jan 30, 2024 | Buy | 40,983 | — | — | SEC |
| Jan 3, 2024 | Award | 3,406 | 0.00 USD | $0 | SEC |
| Oct 2, 2023 | AwardD | 25,099 | 0.00 USD | $0 | SEC |
| Oct 2, 2023 | Award | 3,390 | 0.00 USD | $0 | SEC |
| Jul 3, 2023 | Award | 21,219 | 0.00 USD | $0 | SEC |
| Jul 3, 2023 | AwardD | 42,438 | 0.00 USD | $0 | SEC |
| Jun 30, 2023 | Award | 2,239 | 0.00 USD | $0 | SEC |
| Jun 2, 2023 | AwardD | 125,000 | 0.00 USD | $0 | SEC |
| Apr 27, 2023 | AwardD | 43,026 | 0.00 USD | $0 | SEC |